Do you put weight back on after stopping Wegovy?

Why the weight comes back when you stop

Semaglutide works by activating GLP-1 receptors that reduce hunger signals, slow gastric emptying and shift the body's energy-regulation set-point downward. These effects are present while you take the medicine. When you stop, those signals switch off. Hunger hormones (ghrelin in particular) tend to rebound, appetite returns, and the body's defended weight set-point reasserts itself. This is the same biological mechanism that makes almost any significant weight loss hard to sustain long-term, with or without medication.

The STEP 1 extension trial, published in the New England Journal of Medicine, tracked participants for a year after they stopped semaglutide. By the end of that year, average body weight had returned to within about 5% of participants' original pre-trial weight, meaning roughly two-thirds of the loss was regained. Cardiometabolic markers (blood pressure, blood sugar, cholesterol) moved in the same direction. It's a finding that shapes how clinicians think about treatment duration, and it's the main reason the decision to stop Wegovy is rarely straightforward.

None of this means treatment has failed. It means obesity is a chronic condition. The NHS frames it that way, and so does the NICE guidance that recommends Wegovy only within a structured programme with dietary and activity support running alongside it.

Does everyone regain the same amount?

No. The two-thirds figure is an average across a trial population, and individual outcomes vary considerably. Several factors influence how much weight returns and how quickly.

How long you were on treatment matters. People who reached and stayed at a stable maintenance dose for longer tended to consolidate more of the metabolic and behavioural changes that can persist after stopping. The variation between individuals is real enough that it's worth discussing your specific history with a prescriber rather than assuming the average applies to you.

What you built during treatment matters too. If a year on Wegovy coincided with building consistent exercise habits, improving sleep, reducing ultra-processed food intake and finding sustainable portion sizes, those changes don't evaporate the day you stop, they just lose the pharmacological support. The lifestyle infrastructure you put in place is genuinely protective, even if it can't fully compensate for the return of hunger signals.

The rate of stopping can also be relevant. Abrupt discontinuation after a long period on a higher dose is different from a planned, gradual wind-down with support. This is another reason the conversation with a prescriber matters before you make any changes, not after.

What are the actual options if you're thinking about stopping?

This is the decision the skeleton of this page is built around: you're either already stopping, thinking about it, or trying to decide. Here's how to frame it practically.

If you're stopping because treatment has done its job and you feel confident in your habits, the evidence suggests maintaining those habits is your main lever. That means protein adequacy, strength activity to preserve muscle lost during weight loss, hydration and fibre, practical targets your prescriber or a dietitian can help you set. For a sense of what the cost picture looks like if you're weighing up continuing privately, the Wegovy cost comparison page covers the UK private market honestly.

If you're stopping because of side effects, or because you're not sure the medicine is still right for you, that's a clinical conversation, not something to resolve by reading a page online. Our prescribers at nume review every patient's situation individually before any repeat or change; if you have questions about your treatment, speaking to our prescribers is the right next step.

If you're stopping because you've reached the NICE two-year limit on NHS-funded treatment, you may want to understand what to expect in the weeks after your last dose and how to plan for it. The NHS guidance on weight management injections is clear that stopping should be planned, not abrupt, and that wrap-around support should continue.

Timing is worth thinking about practically too. If a planned stop coincides with a period of higher stress, a holiday abroad or a stretch when your usual routine is disrupted, your prescriber may advise differently than if you're stopping during a settled period. A Monday-morning conversation costs nothing; an unplanned stop mid-treatment can cost more than the medicine did.

Is restarting an option?

Yes, in principle, provided you meet the clinical criteria and a prescriber judges it appropriate. There's no evidence that a period off semaglutide reduces its effectiveness when restarted, though the titration schedule would typically begin again from the lowest dose to protect tolerability. Restarting is a clinical decision, not a self-service one. Wegovy is a prescription-only medicine in the UK, which means a prescriber needs to assess your current health status, weight, any changes in your medical history and your medicines before issuing a new prescription. If you're thinking about restarting treatment after a break, understanding how semaglutide works and what the eligibility criteria look like now is a useful starting point.

The NHS patient information for semaglutide is also worth reading before any restart, it covers contraindications, interactions and what to tell your prescriber about changes in your health since you last took it.